The lymphatic vasculature in disease (original) (raw)

• Schulte-Merker, S., Sabine, A. & Petrova, T.V. Lymphatic vascular morphogenesis in development, physiology, and disease. J. Cell Biol. 193, 607–618 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Pflicke, H. & Sixt, M. Preformed portals facilitate dendritic cell entry into afferent lymphatic vessels. J. Exp. Med. 206, 2925–2935 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Baluk, P. et al. Pathogenesis of persistent lymphatic vessel hyperplasia in chronic airway inflammation. J. Clin. Invest. 115, 247–257 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Dejana, E., Tournier-Lasserve, E. & Weinstein, B.M. The control of vascular integrity by endothelial cell junctions: molecular basis and pathological implications. Dev. Cell 16, 209–221 (2009).
  Article CAS PubMed Google Scholar
• Pfeiffer, F. et al. Distinct molecular composition of blood and lymphatic vascular endothelial cell junctions establishes specific functional barriers within the peripheral lymph node. Eur. J. Immunol. 38, 2142–2155 (2008).
  Article CAS PubMed Google Scholar
• Tal, O., et al. DC mobilization from the skin requires docking to immobilized CCL21 on lymphatic endothelium and intralymphatic crawling. J. Exp. Med. 208, 2141–2153 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Norrmén, C., Tammela, T., Petrova, T.V. & Alitalo, K. Biological basis of therapeutic lymphangiogenesis. Circulation 123, 1335–1351 (2011).
  Article PubMed Google Scholar
• Karkkainen, M.J. et al. Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins. Nat. Immunol. 5, 74–80 (2004).
  Article CAS PubMed Google Scholar
• Wigle, J.T. & Oliver, G. Prox1 function is required for the development of the murine lymphatic system. Cell 98, 769–778 (1999).
  Article CAS PubMed Google Scholar
• Albrecht, I. & Christofori, G. Molecular mechanisms of lymphangiogenesis in development and cancer. Int. J. Dev. Biol. 55, 483–494 (2011).
  Article CAS PubMed Google Scholar
• François, M. et al. Sox18 induces development of the lymphatic vasculature in mice. Nature 456, 643–647 (2008).
  Article CAS PubMed Google Scholar
• Srinivasan, R.S. et al. The nuclear hormone receptor Coup-TFII is required for the initiation and early maintenance of Prox1 expression in lymphatic endothelial cells. Genes Dev. 24, 696–707 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Xu, Y. et al. Neuropilin-2 mediates VEGF-C–induced lymphatic sprouting together with VEGFR3. J. Cell Biol. 188, 115–130 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Mäkinen, T. et al. PDZ interaction site in ephrinB2 is required for the remodeling of lymphatic vasculature. Genes Dev. 19, 397–410 (2005).
  Article PubMed PubMed Central CAS Google Scholar
• Niessen, K. et al. The Notch1-Dll4 signaling pathway regulates mouse postnatal lymphatic development. Blood 118, 1989–1997 (2011).
  Article CAS PubMed Google Scholar
• Zheng, W. et al. Notch restricts lymphatic vessel sprouting induced by vascular endothelial growth factor. Blood 118, 1154–1162 (2011).
  Article CAS PubMed Google Scholar
• Augustin, H.G., Koh, G.Y., Thurston, G. & Alitalo, K. Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system. Nat. Rev. Mol. Cell Biol. 10, 165–177 (2009).
  Article CAS PubMed Google Scholar
• Hogan, B.M. et al. Ccbe1 is required for embryonic lymphangiogenesis and venous sprouting. Nat. Genet. 41, 396–398 (2009).
  Article CAS PubMed Google Scholar
• Bos, F.L. et al. CCBE1 Is Essential for Mammalian lymphatic vascular development and enhances the lymphangiogenic effect of vascular endothelial growth factor-C in vivo. Circ. Res. 109, 486–491 (2011).
  Article CAS PubMed Google Scholar
• Galvagni, F. et al. Endothelial cell adhesion to the extracellular matrix induces c-Src–dependent VEGFR-3 phosphorylation without the activation of the receptor intrinsic kinase activity. Circ. Res. 106, 1839–1848 (2010).
  Article CAS PubMed Google Scholar
• Tammela, T., et al. VEGFR-3 controls tip to stalk conversion at vessel fusion sites by reinforcing Notch signalling. Nat. Cell Biol. 13, 1202–1213 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Uhrin, P. et al. Novel function for blood platelets and podoplanin in developmental separation of blood and lymphatic circulation. Blood 115, 3997–4005 (2010).
  Article CAS PubMed Google Scholar
• Bertozzi, C.C. et al. Platelets regulate lymphatic vascular development through CLEC-2-SLP-76 signaling. Blood 116, 661–670 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Proulx, S.T. et al. Quantitative imaging of lymphatic function with liposomal indocyanine green. Cancer Res. 70, 7053–7062 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Rasmussen, J.C., Tan, I.C., Marshall, M.V., Fife, C.E. & Sevick-Muraca, E.M. Lymphatic imaging in humans with near-infrared fluorescence. Curr. Opin. Biotechnol. 20, 74–82 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Vakoc, B.J. et al. Three-dimensional microscopy of the tumor microenvironment in vivo using optical frequency domain imaging. Nat. Med. 15, 1219–1223 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Song, L., Maslov, K., Shung, K.K. & Wang, L.V. Ultrasound-array–based real-time photoacoustic microscopy of human pulsatile dynamics in vivo. J. Biomed. Opt. 15, 021303 (2010).
  Article PubMed PubMed Central Google Scholar
• Norrmén, C. et al. FOXC2 controls formation and maturation of lymphatic collecting vessels through cooperation with NFATc1. J. Cell Biol. 185, 439–457 (2009).
  Article PubMed PubMed Central CAS Google Scholar
• Kanady, J.D., Dellinger, M.T., Munger, S.J., Witte, M.H. & Simon, A.M. Connexin37 and Connexin43 deficiencies in mice disrupt lymphatic valve development and result in lymphatic disorders including lymphedema and chylothorax. Dev. Biol. 354, 253–266 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Ferrell, R.E. et al. GJC2 missense mutations cause human lymphedema. Am. J. Hum. Genet. 86, 943–948 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Mellor, R.H. et al. Mutations in FOXC2 are strongly associated with primary valve failure in veins of the lower limb. Circulation 115, 1912–1920 (2007).
  Article CAS PubMed Google Scholar
• Bazigou, E. et al. Genes regulating lymphangiogenesis control venous valve formation and maintenance in mice. J. Clin. Invest. 121, 2984–2992 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Karkkainen, M.J. et al. A model for gene therapy of human hereditary lymphedema. Proc. Natl. Acad. Sci. USA 98, 12677–12682 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Ostergaard, P., et al. Mutations in GATA2 cause primary lymphedema associated with a predisposition to acute myeloid leukemia (Emberger syndrome). Nat. Genet. 43, 929–931 (2011).
  Article CAS PubMed Google Scholar
• Stanton, A.W., Modi, S., Mellor, R.H., Levick, J.R. & Mortimer, P.S. Recent advances in breast cancer-related lymphedema of the arm: lymphatic pump failure and predisposing factors. Lymphat. Res. Biol. 7, 29–45 (2009).
  Article PubMed Google Scholar
• McLaughlin, S.A. et al. Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: objective measurements. J. Clin. Oncol. 26, 5213–5219 (2008).
  Article PubMed PubMed Central Google Scholar
• Tammela, T. et al. Therapeutic differentiation and maturation of lymphatic vessels after lymph node dissection and transplantation. Nat. Med. 13, 1458–1466 (2007).
  Article CAS PubMed Google Scholar
• Lähteenvuo, M. et al. Growth factor therapy and autologous lymph node transfer in lymphedema. Circulation 123, 613–620 (2011).
  Article CAS PubMed Google Scholar
• Cormier, J.N., Rourke, L., Crosby, M., Chang, D. & Armer, J. The surgical treatment of lymphedema: a systematic review of the contemporary literature (2004–2010). Ann. Surg. Oncol. published online, doi:10.1245/s10434-011-2017-4 (24 August 2011).
• Saaristo, A.M. et al. Microvascular breast reconstruction and lymph node transfer for postmastectomy lymphedema patients. Ann. Surg. (in the press).
• Becker, C., Assouad, J., Riquet, M. & Hidden, G. Postmastectomy lymphedema: long-term results following microsurgical lymph node transplantation. Ann. Surg. 243, 313–315 (2006).
  Article PubMed PubMed Central Google Scholar
• Tammela, T. & Alitalo, K. Lymphangiogenesis: Molecular mechanisms and future promise. Cell 140, 460–476 (2010).
  Article CAS PubMed Google Scholar
• Rissanen, T.T. et al. VEGF-D is the strongest angiogenic and lymphangiogenic effector among VEGFs delivered into skeletal muscle via adenoviruses. Circ. Res. 92, 1098–1106 (2003).
  Article CAS PubMed Google Scholar
• Anisimov, A. et al. Activated forms of VEGF-C and VEGF-D provide improved vascular function in skeletal muscle. Circ. Res. 104, 1302–1312 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Leppänen, V.M. et al. Structural determinants of growth factor binding and specificity by VEGF receptor 2. Proc. Natl. Acad. Sci. USA 107, 2425–2430 (2010).
  Article PubMed PubMed Central Google Scholar
• Kisko, K. et al. Structural analysis of vascular endothelial growth factor receptor-2/ligand complexes by small-angle X-ray solution scattering. FASEB J. 25, 2980–2986 (2011).
  Article CAS PubMed Google Scholar
• Leppänen, V.M. et al. Structural determinants of vascular endothelial growth factor-D receptor binding and specificity. Blood 117, 1507–1515 (2011).
  Article CAS PubMed Google Scholar
• Vondenhoff, M.F. et al. LTbetaR signaling induces cytokine expression and up-regulates lymphangiogenic factors in lymph node anlagen. J. Immunol. 182, 5439–5445 (2009).
  Article CAS PubMed Google Scholar
• Vondenhoff, M.F. et al. Lymph sacs are not required for the initiation of lymph node formation. Development 136, 29–34 (2009).
  Article CAS PubMed Google Scholar
• Förster, R., Davalos-Misslitz, A.C. & Rot, A. CCR7 and its ligands: balancing immunity and tolerance. Nat. Rev. Immunol. 8, 362–371 (2008).
  Article CAS PubMed Google Scholar
• Wick, N. et al. Lymphatic precollectors contain a novel, specialized subpopulation of podoplanin low, CCL27-expressing lymphatic endothelial cells. Am. J. Pathol. 173, 1202–1209 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Pham, T.H. et al. Lymphatic endothelial cell sphingosine kinase activity is required for lymphocyte egress and lymphatic patterning. J. Exp. Med. 207, 17–27 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Karikoski, M. et al. Clever-1/Stabilin-1 regulates lymphocyte migration within lymphatics and leukocyte entrance to sites of inflammation. Eur. J. Immunol. 39, 3477–3487 (2009).
  Article CAS PubMed Google Scholar
• Roozendaal, R. et al. Conduits mediate transport of low-molecular-weight antigen to lymph node follicles. Immunity 30, 264–276 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Alvarez, D., Vollmann, E.H. & von Andrian, U.H. Mechanisms and consequences of dendritic cell migration. Immunity 29, 325–342 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Phan, T.G., Green, J.A., Gray, E.E., Xu, Y. & Cyster, J.G. Immune complex relay by subcapsular sinus macrophages and noncognate B cells drives antibody affinity maturation. Nat. Immunol. 10, 786–793 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Kunder, C.A. et al. Mast cell-derived particles deliver peripheral signals to remote lymph nodes. J. Exp. Med. 206, 2455–2467 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Cohen, J.N. et al. Lymph node–resident lymphatic endothelial cells mediate peripheral tolerance via Aire-independent direct antigen presentation. J. Exp. Med. 207, 681–688 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Kang, S. et al. Toll-like receptor 4 in lymphatic endothelial cells contributes to LPS-induced lymphangiogenesis by chemotactic recruitment of macrophages. Blood 113, 2605–2613 (2009).
  Article CAS PubMed Google Scholar
• Kataru, R.P. et al. Critical role of CD11b+ macrophages and VEGF in inflammatory lymphangiogenesis, antigen clearance and inflammation resolution. Blood 113, 5650–5659 (2009).
  Article CAS PubMed Google Scholar
• Huggenberger, R. et al. An important role of lymphatic vessel activation in limiting acute inflammation. Blood 117, 4667–4678 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Angeli, V. et al. B cell–driven lymphangiogenesis in inflamed lymph nodes enhances dendritic cell mobilization. Immunity 24, 203–215 (2006).
  Article CAS PubMed Google Scholar
• Kataru, R.P. et al. T lymphocytes negatively regulate lymph node lymphatic vessel formation. Immunity 34, 96–107 (2011).
  Article CAS PubMed Google Scholar
• Cueni, L.N. & Detmar, M. The lymphatic system in health and disease. Lymphat. Res. Biol. 6, 109–122 (2008).
  Article PubMed Google Scholar
• von der Weid, P.Y., Rehal, S. & Ferraz, J.G. Role of the lymphatic system in the pathogenesis of Crohn's disease. Curr. Opin. Gastroenterol. 27, 335–341 (2011).
  Article CAS PubMed Google Scholar
• Kerjaschki, D. et al. Lymphatic endothelial progenitor cells contribute to de novo lymphangiogenesis in human renal transplants. Nat. Med. 12, 230–234 (2006).
  Article CAS PubMed Google Scholar
• Nykänen, A.I. et al. Targeting lymphatic vessel activation and CCL21 production by vascular endothelial growth factor receptor-3 inhibition has novel immunomodulatory and antiarteriosclerotic effects in cardiac allografts. Circulation 121, 1413–1422 (2010).
  Article CAS PubMed Google Scholar
• Albuquerque, R.J. et al. Alternatively spliced vascular endothelial growth factor receptor-2 is an essential endogenous inhibitor of lymphatic vessel growth. Nat. Med. 15, 1023–1030 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Yin, N. et al. Targeting lymphangiogenesis after islet transplantation prolongs islet allograft survival. Transplantation 92, 25–30 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Lämmermann, T. et al. Rapid leukocyte migration by integrin-independent flowing and squeezing. Nature 453, 51–55 (2008).
  Article PubMed CAS Google Scholar
• Miteva, D.O. et al. Transmural flow modulates cell and fluid transport functions of lymphatic endothelium. Circ. Res. 106, 920–931 (2010).
  Article CAS PubMed Google Scholar
• Schumann, K. et al. Immobilized chemokine fields and soluble chemokine gradients cooperatively shape migration patterns of dendritic cells. Immunity 32, 703–713 (2010).
  Article CAS PubMed Google Scholar
• Johnson, L.A. & Jackson, D.G. Inflammation-induced secretion of CCL21 in lymphatic endothelium is a key regulator of integrin-mediated dendritic cell transmigration. Int. Immunol. 22, 839–849 (2010).
  Article CAS PubMed Google Scholar
• Bao, X. et al. Endothelial heparan sulfate controls chemokine presentation in recruitment of lymphocytes and dendritic cells to lymph nodes. Immunity 33, 817–829 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Podgrabinska, S. et al. Inflamed lymphatic endothelium suppresses dendritic cell maturation and function via Mac-1/ICAM-1–dependent mechanism. J. Immunol. 183, 1767–1779 (2009).
  Article CAS PubMed Google Scholar
• Vetrano, S. et al. The lymphatic system controls intestinal inflammation and inflammation-associated colon cancer through the chemokine decoy receptor D6. Gut 59, 197–206 (2010).
  Article PubMed Google Scholar
• Gräbner, R. et al. Lymphotoxin Β receptor signaling promotes tertiary lymphoid organogenesis in the aorta adventitia of aged _Apoe_−/− mice. J. Exp. Med. 206, 233–248 (2009).
  Article PubMed PubMed Central CAS Google Scholar
• van de Pavert, S.A. & Mebius, R.E. New insights into the development of lymphoid tissues. Nat. Rev. Immunol. 10, 664–674 (2010).
  Article CAS PubMed Google Scholar
• Muniz, L.R., Pacer, M.E., Lira, S.A. & Furtado, G.C. A critical role for dendritic cells in the formation of lymphatic vessels within tertiary lymphoid structures. J. Immunol. 187, 828–834 (2011).
  Article CAS PubMed Google Scholar
• Mounzer, R.H. et al. Lymphotoxin-Α contributes to lymphangiogenesis. Blood 116, 2173–2182 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Harvey, N.L. The link between lymphatic function and adipose biology. Ann. NY Acad. Sci. 1131, 82–88 (2008).
  Article PubMed Google Scholar
• Dixon, J.B. Lymphatic lipid transport: sewer or subway? Trends Endocrinol. Metab. 21, 480–487 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Harvey, N.L. et al. Lymphatic vascular defects promoted by Prox1 haploinsufficiency cause adult-onset obesity. Nat. Genet. 37, 1072–1081 (2005).
  Article CAS PubMed Google Scholar
• Rutkowski, J.M. et al. Dermal collagen and lipid deposition correlate with tissue swelling and hydraulic conductivity in murine primary lymphedema. Am. J. Pathol. 176, 1122–1129 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Szuba, A. et al. Therapeutic lymphangiogenesis with human recombinant VEGF-C. FASEB J. 16, 1985–1987 (2002).
  Article CAS PubMed Google Scholar
• Libby, P., Ridker, P.M. & Hansson, G.K. Inflammation in atherosclerosis: from pathophysiology to practice. J. Am. Coll. Cardiol. 54, 2129–2138 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Kholová, I. et al. Lymphatic vasculature is increased in heart valves, ischaemic and inflamed hearts and in cholesterol-rich and calcified atherosclerotic lesions. Eur. J. Clin. Invest. 41, 487–497 (2011).
  Article PubMed Google Scholar
• Nakano, T. et al. Angiogenesis and lymphangiogenesis and expression of lymphangiogenic factors in the atherosclerotic intima of human coronary arteries. Hum. Pathol. 36, 330–340 (2005).
  Article CAS PubMed Google Scholar
• Lim, H.Y. et al. Hypercholesterolemic mice exhibit lymphatic vessel dysfunction and degeneration. Am. J. Pathol. 175, 1328–1337 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Machnik, A. et al. Macrophages regulate salt-dependent volume and blood pressure by a vascular endothelial growth factor-C–dependent buffering mechanism. Nat. Med. 15, 545–552 (2009).
  Article CAS PubMed Google Scholar
• Wang, H.W. et al. Kaposi sarcoma herpesvirus-induced cellular reprogramming contributes to the lymphatic endothelial gene expression in Kaposi sarcoma. Nat. Genet. 36, 687–693 (2004).
  Article CAS PubMed Google Scholar
• Cheng, F. et al. Virus-induced Notch-MT1-MMP axis leads to lymphatic endothelial-to-mesenchymal transition. Cell Host. Microbe (in the press).
• Liu, R. et al. KSHV-induced notch components render endothelial and mural cell characteristics and cell survival. Blood 115, 887–895 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Zhang, X. et al. Kaposi's sarcoma–associated herpesvirus activation of vascular endothelial growth factor receptor 3 alters endothelial function and enhances infection. J. Biol. Chem. 280, 26216–26224 (2005).
  Article CAS PubMed Google Scholar
• Tvorogov, D. et al. Effective suppression of vascular network formation by combination of antibodies blocking VEGFR ligand binding and receptor dimerization. Cancer Cell 18, 630–640 (2010).
  Article CAS PubMed Google Scholar
• Harari, S., Torre, O. & Moss, J. Lymphangioleiomyomatosis: what do we know and what are we looking for? Eur. Respir. Rev. 20, 34–44 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• McCormack, F.X. et al. Efficacy and safety of sirolimus in lymphangioleiomyomatosis. N. Engl. J. Med. 364, 1595–1606 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Seyama, K. et al. Vascular endothelial growth factor-D is increased in serum of patients with lymphangioleiomyomatosis. Lymphat. Res. Biol. 4, 143–152 (2006).
  Article CAS PubMed Google Scholar
• Fukumura, D., Duda, D.G., Munn, L.L. & Jain, R.K. Tumor microvasculature and microenvironment: novel insights through intravital imaging in pre-clinical models. Microcirculation 17, 206–225 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Mumprecht, V. et al. In vivo imaging of inflammation- and tumor-induced lymph node lymphangiogenesis by immuno-positron emission tomography. Cancer Res. 70, 8842–8851 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Leijte, J.A., van der Ploeg, I.M., Valdes Olmos, R.A., Nieweg, O.E. & Horenblas, S. Visualization of tumor blockage and rerouting of lymphatic drainage in penile cancer patients by use of SPECT/CT. J. Nucl. Med. 50, 364–367 (2009).
  Article PubMed Google Scholar
• Giuliano, A.E., et al. Association of occult metastases in sentinel lymph nodes and bone marrow with survival among women with early-stage invasive breast cancer. J. Am. Med. Assoc. 306, 385–393 (2011).
  Article CAS Google Scholar
• Louis-Sylvestre, C. et al. Axillary treatment in conservative management of operable breast cancer: dissection or radiotherapy? Results of a randomized study with 15 years of follow-up. J. Clin. Oncol. 22, 97–101 (2004).
  Article PubMed Google Scholar
• Chaffer, C.L. & Weinberg, R.A. A perspective on cancer cell metastasis. Science 331, 1559–1564 (2011).
  Article CAS PubMed Google Scholar
• Sleeman, J.P., Nazarenko, I. & Thiele, W. Do all roads lead to Rome? Routes to metastasis development. Int. J. Cancer 128, 2511–2526 (2011).
  Article CAS PubMed Google Scholar
• Stoecklein, N.H. & Klein, C.A. Genetic disparity between primary tumours, disseminated tumour cells and manifest metastasis. Int. J. Cancer 126, 589–598 (2010).
  Article CAS PubMed Google Scholar
• Campbell, P.J. et al. The patterns and dynamics of genomic instability in metastatic pancreatic cancer. Nature 467, 1109–1113 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Shields, J.D., Kourtis, I.C., Tomei, A.A., Roberts, J.M. & Swartz, M.A. Induction of lymphoidlike stroma and immune escape by tumors that express the chemokine CCL21. Science 328, 749–752 (2010).
  Article CAS PubMed Google Scholar
• Kim, M. et al. CXCR4 signaling regulates metastasis of chemoresistant melanoma cells by a lymphatic metastatic niche. Cancer Res. 70, 10411–10421 (2010).
  Article CAS PubMed Google Scholar
• Madsen, C.D. & Sahai, E. Cancer dissemination—lessons from leukocytes. Dev. Cell 19, 13–26 (2010).
  Article CAS PubMed Google Scholar
• Contassot, E., Preynat-Seauve, O., French, L. & Huard, B. Lymph node tumor metastases: more susceptible than primary tumors to CD8+ T cell immune destruction. Trends Immunol. 30, 569–573 (2009).
  Article CAS PubMed Google Scholar
• Kerjaschki, D. et al. Lipoxygenase mediates invasion of intrametastatic lymphatic vessels and propagates lymph node metastasis of human mammary carcinoma xenografts in mouse. J. Clin. Invest. 121, 2000–2012 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Tammela, T. et al. Blocking VEGFR-3 suppresses angiogenic sprouting and vascular network formation. Nature 454, 656–660 (2008).
  Article CAS PubMed Google Scholar
• Roberts, N. et al. Inhibition of VEGFR-3 activation with the antagonistic antibody more potently suppresses lymph node and distant metastases than inactivation of VEGFR-2. Cancer Res. 66, 2650–2657 (2006).
  Article CAS PubMed Google Scholar
• Caunt, M. et al. Blocking neuropilin-2 function inhibits tumor cell metastasis. Cancer Cell 13, 331–342 (2008).
  Article CAS PubMed Google Scholar
• Hooper, A.T. et al. Engraftment and reconstitution of hematopoiesis is dependent on VEGFR2-mediated regeneration of sinusoidal endothelial cells. Cell Stem Cell 4, 263–274 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Zbytek, B. et al. Current concepts of metastasis in melanoma. Expert Rev. Dermatol. 3, 569–585 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Tammela, T. et al. Photodynamic ablation of lymphatic vessels and intralymphatic cancer cells prevents metastasis. Sci. Transl. Med. 3, 69ra11 (2011).
  Article CAS PubMed Google Scholar
• Goyal, S., Chauhan, S.K. & Dana, R. Blockade of prolymphangiogenic vascular endothelial growth factor C in dry eye disease. Arch. Ophthalmol. published online, doi:10.1001/archophthalmol.2011.266 (12 September 2011).
  Article PubMed Google Scholar
• Koch, S., Tugues, S., Li, X., Gualandi, L. & Claesson-Welsh, L. Signal transduction by vascular endothelial growth factor receptors. Biochem. J. 437, 169–183 (2011).
  Article CAS PubMed Google Scholar
• Saharinen, P. et al. Claudin-like protein 24 interacts with the VEGFR-2 and VEGFR-3 pathways and regulates lymphatic vessel development. Genes Dev. 24, 875–880 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Yang, Y., Xie, P., Opatowsky, Y. & Schlessinger, J. Direct contacts between extracellular membrane-proximal domains are required for VEGF receptor activation and cell signaling. Proc. Natl. Acad. Sci. USA 107, 1906–1911 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Kendrew, J. et al. An antibody targeted to VEGFR-2 Ig domains 4–7 inhibits VEGFR-2 activation and VEGFR-2–dependent angiogenesis without affecting ligand binding. Mol. Cancer Ther. 10, 770–783 (2011).
  Article CAS PubMed Google Scholar
• Koh, Y.J. et al. Double antiangiogenic protein, DAAP, targeting VEGF-A and angiopoietins in tumor angiogenesis, metastasis and vascular leakage. Cancer Cell 18, 171–184 (2010).
  Article CAS PubMed Google Scholar
• Hashizume, H. et al. Complementary actions of inhibitors of angiopoietin-2 and VEGF on tumor angiogenesis and growth. Cancer Res. 70, 2213–2223 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Brown, J.L. et al. A human monoclonal anti-ANG2 antibody leads to broad antitumor activity in combination with VEGF inhibitors and chemotherapy agents in preclinical models. Mol. Cancer Ther. 9, 145–156 (2010).
  Article CAS PubMed Google Scholar